Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-amoxiclav 500mg/125mg tablets
0501013K0AAAJAJ
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 202,621 |
|
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free
0501013K0AAAGAG
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 20,212 |
|
Co-amoxiclav 250mg/125mg tablets
0501013K0AAAAAA
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 18,870 |
|
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free
0501013K0AAADAD
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 6,685 |
|
Co-amoxiclav 125mg/31mg/5ml oral suspension
0501013K0AAAHAH
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 5,897 |
|
Co-amoxiclav 250mg/62mg/5ml oral suspension
0501013K0AAAIAI
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 5,734 |
|
Co-amoxiclav 400mg/57mg/5ml oral suspension sugar free
0501013K0AAAKAK
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 2,669 |
|
Co-amoxiclav 400mg/57mg/5ml oral suspension
0501013K0AAAPAP
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 380 |
|
Co-amoxiclav 875mg/125mg tablets
0501013K0AAANAN
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 15 |
|
Co-amoxiclav 500mg/100mg inj vials
0501013K0AAAEAE
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 5 |
|
Co-amoxiclav 1000mg/200mg inj vials
0501013K0AAAFAF
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 4 |
|
Co-amoxiclav 250mg/125mg dispersible tablets sugar free
0501013K0AAABAB
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.